Results: Forty-four subjects were randomized at baseline, and 39 completed
the study (G cambogia group, n 18; placebo group, n 21). At 16 weeks, the
G cambogia group had significantly reduced visceral, subcutaneous, and total
fat areas compared with the placebo group (all indices P 0.001). No severe
adverse effect was observed at any time in the test period.